复方血塞通联合康柏西普治疗病理性近视脉络膜新生血管疗.PDFVIP

  • 17
  • 0
  • 约1.51万字
  • 约 4页
  • 2017-06-07 发布于湖北
  • 举报

复方血塞通联合康柏西普治疗病理性近视脉络膜新生血管疗.PDF

Int Eye Sci,Vol.17,No.6,Jun. 2017摇 摇 http:/ / Tel:029 摇 Email:IJO.2000@163.com ·临床报告 · 复方血塞通联合康柏西普治疗病理性近视脉络膜新生血 管的疗效 黄鹤龄,方一惟,陈欣华,李摇 平 作者单位:(617067)中国四川省攀枝花市中心医院眼科 誗CONCLUSION: Compound xuesaitong combined with 作者简介:黄鹤龄,副主任医师,研究方向:临床眼科。 conbercept can effectively reduce CMT and IOP, reduce 通讯作者:黄鹤龄.redleafling@163.com the area of CNV and significantly improve visual acuity. 收稿日期:2017-01-21摇 摇 修回日期:2017-05-10 Its anti-VEGFeffect is obvious,safe andfeasible. 誗KEYWORDS:choroidal neovascularization in patients Curative effect of compound Xuesaitong with pathological myopia; compound xuesaitong; combined with Conbercept in the conbercept treatment of choroidal neovascularization in pathological myopia Citation:Huang HL,Fang YW,Chen XH,et al. Curative effect of compound Xuesaitong combined with Conbercept in the treatment He-Ling Huang, Yi-Wei Fang, Xin-Hua Chen, of choroidal neovascularization in pathological myopia. Guoji Yanke Ping Li Zazhi(Int Eye Sci)2017;17(6):1167-1170 Department of Ophthalmology, Central Hospital of Panzhihua, 摘要 Panzhihua617067,Sichuan Province,China 目的:分析复方血塞通联合康柏西普对病理性近视脉络膜 Correspondence to: He - Ling Huang. Department of 新生血管(choroidal neovascularization,CNV)患者黄斑中心 Ophthalmology,Central Hospital of Panzhihua,Panzhihua 617067, 视网膜厚度(central macular retinal thickness,CMT)、荧光 Sichuan Province,China. redleafling@163.com 素眼底血管造影及最佳矫正视力(BCVA)的影响。 Received:20

文档评论(0)

1亿VIP精品文档

相关文档